AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 73 filers reported holding AURA BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 10.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $129 | -35.2% | 17,113 | -32.6% | 0.00% | – |
| Q1 2024 | $199 | -41.1% | 25,394 | -33.5% | 0.00% | – |
| Q4 2023 | $338 | +686.0% | 38,169 | +683.1% | 0.00% | – |
| Q3 2023 | $43 | -87.5% | 4,874 | -82.5% | 0.00% | – |
| Q2 2023 | $344 | +7.5% | 27,852 | -19.1% | 0.00% | – |
| Q1 2023 | $320 | -16.7% | 34,417 | -5.8% | 0.00% | – |
| Q4 2022 | $384 | -99.9% | 36,519 | -13.1% | 0.00% | -100.0% |
| Q3 2022 | $762,000 | +27.4% | 42,044 | -0.3% | 0.00% | – |
| Q2 2022 | $598,000 | -54.5% | 42,186 | -29.3% | 0.00% | -100.0% |
| Q1 2022 | $1,314,000 | – | 59,697 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $31,918,866 | 13.40% |
| Regency Capital Management Inc.\DE | 554,286 | $5,820,003 | 6.69% |
| Decheng Capital Management III (Cayman), LLC | 293,333 | $3,079,997 | 1.15% |
| Matrix Capital Management Company, LP | 5,362,870 | $56,310,135 | 1.08% |
| Monashee Investment Management LLC | 131,640 | $1,382,220 | 0.60% |
| Nantahala Capital Management | 798,751 | $8,386,886 | 0.54% |
| Eventide Asset Management | 2,251,368 | $23,639,364 | 0.47% |
| Rock Springs Capital Management LP | 1,019,757 | $10,707,449 | 0.26% |
| Artal Group S.A. | 410,000 | $4,305 | 0.24% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,132,739 | $22,393,760 | 0.05% |